Advisor Group Holdings, Inc. Nu Cana PLC Transaction History

Advisor Group Holdings, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$0.22 - $4.45 $368 - $7,453	1,675 New	1,675 $4,000
Q4 2023 Feb 12, 2024	BUY	$0.26 - $0.8 $435 - $1,340	1,675 New	1,675 $0
Q3 2022 Nov 14, 2022	SELL	$0.62 - $26.13 $136 - $5,748	-220 Reduced 80.29%	54 $0
Q2 2022 Aug 10, 2022	BUY	$0.59 - $1.06 $70 - $127	120 Added 77.92%	274 $0
Q1 2021 May 13, 2021	BUY	$4.38 - $7.0 $236 - $378	54 Added 54.0%	154 $1,000
Q1 2020 May 18, 2020	BUY	$4.02 - $9.05 $401 - $905	100 New	100 $1,000

3.33M

Ticker NCNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,196,000
Market Cap $69.9M
Description
NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of products for the treatment of cancer. The company develops its products based on its proprietary ProTide technology. Its lead product candidate includes Acelarin, which is in Phase I clinical trial for patients with advanced solid tumors; Phase Ib for patients ...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.